CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Extended Vision IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04591054
NCT04591054N/ACompleted
CompareCT.gov

Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses

Milton S. Hershey Medical Center·interventional·Posted Oct 19, 2020·Updated Aug 21, 2023

In Brief

A clinical study evaluating Extended Vision IOL and Neutral Aspheric Monofocal IOL for Cataract and Presbyopia. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the binocular distance, intermediate, and near visual acuity of the Alcon Vivity and Bausch \& Lomb enVista IOLs. We hypothesize that the Alcon Vivity and Bausch \& Lomb enVista IOLs will have similar distance, intermediate, and near visual acuity. If the null hypothesis is rejected, then the visual performance of the IOLs may be different.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Presbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 19, 2020
Enrollment StartNov 20, 2020
Primary CompletionJul 26, 2022
Study CompletionAug 24, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.7 years ago

Interventions

Extended Vision IOLdevice

Vivity IOL implantation following cataract extraction

Neutral Aspheric Monofocal IOLdevice

enVista IOL implantation following cataract extraction